GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » FCF Margin %

VGI Health Technology (XNEC:VTL) FCF Margin % : 0.00% (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. VGI Health Technology's Free Cash Flow for the six months ended in . 20 was A$0.00 Mil. VGI Health Technology's Revenue for the six months ended in . 20 was A$0.00 Mil. Therefore, VGI Health Technology's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, VGI Health Technology's current FCF Yield % is 0.00%.

The historical rank and industry rank for VGI Health Technology's FCF Margin % or its related term are showing as below:


XNEC:VTL's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -139.2
* Ranked among companies with meaningful FCF Margin % only.


VGI Health Technology FCF Margin % Historical Data

The historical data trend for VGI Health Technology's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology FCF Margin % Chart

VGI Health Technology Annual Data
Trend
FCF Margin %

VGI Health Technology Semi-Annual Data
FCF Margin %

Competitive Comparison of VGI Health Technology's FCF Margin %

For the Biotechnology subindustry, VGI Health Technology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VGI Health Technology's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's FCF Margin % distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's FCF Margin % falls into.



VGI Health Technology FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

VGI Health Technology's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

VGI Health Technology's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VGI Health Technology FCF Margin % Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


VGI Health Technology (XNEC:VTL) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003
VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines